As far as I am aware, the answer to the original question is a no.
Australia uses evidence based practice. Meaning anything done by a healthcare professional SHOULD always be able to fall back onto research to justify their actions.
Therefore a GP would be taking one hell of a risk by prescribing a drug meant for one use, for another, without the backing of research to suggest its appropriate.
Happy to be proven wrong, but I'm fairly confident its a no, that would defeat the entire purpose of doing all of these studies in the first place if a GP could go "hmmm lets have a go at using Ventolin to cure athletes foot, it might work, lets have a crack"
- Forums
- ASX - By Stock
- NEU
- Application
Application, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.24 |
Change
0.140(0.70%) |
Mkt cap ! $2.607B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $1.633M | 80.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65 | $20.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.25 | 155 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 34 | 20.310 |
7 | 407 | 20.290 |
3 | 184 | 20.280 |
4 | 535 | 20.270 |
5 | 409 | 20.260 |
Price($) | Vol. | No. |
---|---|---|
20.320 | 81 | 10 |
20.330 | 40 | 3 |
20.340 | 376 | 4 |
20.350 | 180 | 3 |
20.360 | 198 | 3 |
Last trade - 14.23pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |